Menu
GeneBe

rs143662421

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_020937.4(FANCM):ā€‹c.5224A>Gā€‹(p.Ile1742Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0107 in 1,614,072 control chromosomes in the GnomAD database, including 118 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.0081 ( 10 hom., cov: 32)
Exomes š‘“: 0.011 ( 108 hom. )

Consequence

FANCM
NM_020937.4 missense

Scores

18

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:8

Conservation

PhyloP100: -0.432
Variant links:
Genes affected
FANCM (HGNC:23168): (FA complementation group M) The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group M. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.002847463).
BP6
Variant 14-45189246-A-G is Benign according to our data. Variant chr14-45189246-A-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 241324.We mark this variant Likely_benign, oryginal submissions are: {Benign=5, Likely_benign=1, Uncertain_significance=1}. Variant chr14-45189246-A-G is described in Lovd as [Benign]. Variant chr14-45189246-A-G is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00813 (1239/152310) while in subpopulation NFE AF= 0.0123 (838/68024). AF 95% confidence interval is 0.0116. There are 10 homozygotes in gnomad4. There are 607 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 10 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
FANCMNM_020937.4 linkuse as main transcriptc.5224A>G p.Ile1742Val missense_variant 20/23 ENST00000267430.10

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
FANCMENST00000267430.10 linkuse as main transcriptc.5224A>G p.Ile1742Val missense_variant 20/231 NM_020937.4 P1Q8IYD8-1

Frequencies

GnomAD3 genomes
AF:
0.00813
AC:
1237
AN:
152192
Hom.:
10
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00210
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.00752
Gnomad ASJ
AF:
0.0196
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00290
Gnomad FIN
AF:
0.00828
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0123
Gnomad OTH
AF:
0.0129
GnomAD3 exomes
AF:
0.00864
AC:
2169
AN:
251052
Hom.:
22
AF XY:
0.00909
AC XY:
1233
AN XY:
135656
show subpopulations
Gnomad AFR exome
AF:
0.00209
Gnomad AMR exome
AF:
0.00604
Gnomad ASJ exome
AF:
0.0236
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00294
Gnomad FIN exome
AF:
0.00735
Gnomad NFE exome
AF:
0.0122
Gnomad OTH exome
AF:
0.00947
GnomAD4 exome
AF:
0.0110
AC:
16051
AN:
1461762
Hom.:
108
Cov.:
32
AF XY:
0.0109
AC XY:
7944
AN XY:
727186
show subpopulations
Gnomad4 AFR exome
AF:
0.00212
Gnomad4 AMR exome
AF:
0.00660
Gnomad4 ASJ exome
AF:
0.0221
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00304
Gnomad4 FIN exome
AF:
0.00618
Gnomad4 NFE exome
AF:
0.0124
Gnomad4 OTH exome
AF:
0.0102
GnomAD4 genome
AF:
0.00813
AC:
1239
AN:
152310
Hom.:
10
Cov.:
32
AF XY:
0.00815
AC XY:
607
AN XY:
74470
show subpopulations
Gnomad4 AFR
AF:
0.00209
Gnomad4 AMR
AF:
0.00751
Gnomad4 ASJ
AF:
0.0196
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00311
Gnomad4 FIN
AF:
0.00828
Gnomad4 NFE
AF:
0.0123
Gnomad4 OTH
AF:
0.0128
Alfa
AF:
0.0122
Hom.:
25
Bravo
AF:
0.00835
TwinsUK
AF:
0.0113
AC:
42
ALSPAC
AF:
0.0122
AC:
47
ESP6500AA
AF:
0.00409
AC:
18
ESP6500EA
AF:
0.0141
AC:
121
ExAC
AF:
0.00840
AC:
1020
Asia WGS
AF:
0.00115
AC:
4
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:8
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Benign:3
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, Amsterdam University Medical Center-- -
Benign, criteria provided, single submitterclinical testingQuest Diagnostics Nichols Institute San Juan CapistranoApr 23, 2021- -
not provided Benign:3
Likely benign, criteria provided, single submitterclinical testingGeneDxMar 23, 2021This variant is associated with the following publications: (PMID: 29351780, 28202063) -
Likely benign, no assertion criteria providedclinical testingLaboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)-- -
Benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJul 01, 2024FANCM: BP4, BS1, BS2 -
Spermatogenic failure 28 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingBaylor GeneticsJul 24, 2019This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. -
Fanconi anemia Benign:1
Benign, criteria provided, single submitterclinical testingInvitaeFeb 01, 2024- -
Hereditary cancer-predisposing syndrome Benign:1
Benign, criteria provided, single submittercurationSema4, Sema4Feb 24, 2020- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.061
BayesDel_addAF
Benign
-0.58
T
BayesDel_noAF
Benign
-0.59
CADD
Benign
0.028
DANN
Benign
0.22
DEOGEN2
Benign
0.042
T;.;.
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.0029
N
LIST_S2
Benign
0.54
T;T;T
MetaRNN
Benign
0.0028
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-1.4
N;.;.
MutationTaster
Benign
1.0
N;N
PrimateAI
Benign
0.21
T
PROVEAN
Benign
-0.020
N;N;N
REVEL
Benign
0.10
Sift
Benign
1.0
T;T;T
Sift4G
Benign
1.0
T;T;T
Polyphen
0.0
B;.;.
Vest4
0.015
MVP
0.39
MPC
0.071
ClinPred
0.00054
T
GERP RS
-2.3
Varity_R
0.018
gMVP
0.16

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs143662421; hg19: chr14-45658449; COSMIC: COSV104566871; COSMIC: COSV104566871; API